Pharmanutra S.p.A. (FRA:761)
Germany · Delayed Price · Currency is EUR 62.80
-0.20 (-0.32%)
At close: Jan 30, 2026
Pharmanutra Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 17.45 | 16.61 | 12.83 | 15.05 | 13.77 | 14.07 |
Depreciation & Amortization | 3.48 | 3.34 | 2.42 | 1.15 | 1.01 | 0.93 |
Other Amortization | 0.17 | 0.17 | - | - | - | - |
Provision & Write-off of Bad Debts | 0.24 | 0.14 | 0.21 | 0.17 | 0.15 | 1.25 |
Other Operating Activities | 0.67 | 1.19 | 1.41 | 0.81 | 1.26 | 0.36 |
Change in Accounts Receivable | -2.64 | -2.98 | 2.22 | -5.15 | -1.77 | -1.28 |
Change in Inventory | -2.26 | 1.22 | -2.91 | -2.4 | -0.97 | -0.04 |
Change in Accounts Payable | 1.97 | 1.43 | -0.78 | 7.14 | 2.58 | -0.99 |
Change in Income Taxes | 0.03 | 0.02 | 2.55 | -3.04 | 3.59 | -1.62 |
Change in Other Net Operating Assets | -4.65 | -0.7 | -5.87 | 3.74 | 0.81 | -0.89 |
Operating Cash Flow | 14.45 | 20.5 | 12.09 | 17.47 | 20.41 | 11.8 |
Operating Cash Flow Growth | -36.83% | 69.56% | -30.77% | -14.44% | 73.02% | -1.54% |
Capital Expenditures | -4.02 | -4.25 | -13.25 | -26.16 | -4.99 | -1.68 |
Sale of Property, Plant & Equipment | 0.44 | 0.66 | 0.55 | 0.27 | 0.08 | 0.35 |
Investment in Securities | 0.27 | - | - | 0.25 | - | - |
Other Investing Activities | 0.25 | 1.38 | -2.01 | -1.08 | -0.64 | 0.73 |
Investing Cash Flow | -3.07 | -2.21 | -14.7 | -26.72 | -5.54 | -0.6 |
Short-Term Debt Issued | - | - | - | - | - | 0 |
Long-Term Debt Issued | - | 0.62 | 10.99 | 15.41 | 5.41 | - |
Total Debt Issued | 0.98 | 0.62 | 10.99 | 15.41 | 5.41 | 0 |
Short-Term Debt Repaid | - | - | - | - | - | -3.76 |
Long-Term Debt Repaid | - | -6.11 | -0.7 | -4.04 | -0.72 | -0.98 |
Total Debt Repaid | -4.48 | -6.11 | -0.7 | -4.04 | -0.72 | -4.74 |
Net Debt Issued (Repaid) | -3.5 | -5.49 | 10.29 | 11.38 | 4.69 | -4.74 |
Issuance of Common Stock | 0.08 | - | - | - | - | - |
Repurchase of Common Stock | -0.6 | -0.55 | -1.65 | -2.36 | - | -0.03 |
Common Dividends Paid | -9.59 | -8.17 | -7.71 | -6.85 | -6.49 | -4.45 |
Other Financing Activities | -0.82 | -7.38 | -1.44 | -0.27 | -0.12 | 0.73 |
Financing Cash Flow | -14.43 | -21.59 | -0.52 | 1.89 | -1.92 | -8.5 |
Miscellaneous Cash Flow Adjustments | 14.06 | - | - | - | - | - |
Net Cash Flow | 11.01 | -3.31 | -3.13 | -7.36 | 12.95 | 2.7 |
Free Cash Flow | 10.42 | 16.25 | -1.16 | -8.69 | 15.43 | 10.12 |
Free Cash Flow Growth | -46.33% | - | - | - | 52.49% | 42.08% |
Free Cash Flow Margin | 8.20% | 13.99% | -1.15% | -10.46% | 22.64% | 17.82% |
Free Cash Flow Per Share | 1.09 | 1.69 | -0.12 | -0.90 | 1.59 | 1.04 |
Levered Free Cash Flow | 11.88 | 12.86 | 2.25 | -14.67 | 11.35 | 5.51 |
Unlevered Free Cash Flow | 12.35 | 13.53 | 2.75 | -14.63 | 11.36 | 5.53 |
Change in Working Capital | -7.55 | -1.01 | -4.78 | 0.29 | 4.23 | -4.82 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.